https://orcid.org/0000-0002-1585-8099
Citations (114)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (32)
Yang Qian, Chenting Cai, Mengqing Sun, Dan Lv & Yun Zhao. (2023) Analyses of Factors Associated with Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Review. International Journal of Chronic Obstructive Pulmonary Disease 18, pages 2707-2723.
Read now
Read now
Kieran J Rothnie, Beade Numbere, Steven Gelwicks, Yifei Lu, Raj Sharma, Chris Compton, Afisi S Ismaila & Jennifer K Quint. (2023) Risk Factors Associated with a First Exacerbation Among Patients with COPD Classified as GOLD A and B in Routine Clinical Practice in the UK. International Journal of Chronic Obstructive Pulmonary Disease 18, pages 2673-2685.
Read now
Read now
Juan José Soler-Cataluña, José Luis Izquierdo, Mónica Juárez Campo, Antoni Sicras-Mainar & Javier Nuevo. (2023) Impact of COPD Exacerbations and Burden of Disease in Spain: AVOIDEX Study. International Journal of Chronic Obstructive Pulmonary Disease 18, pages 1103-1114.
Read now
Read now
Hong Wang, Tao Yang, Xiaodan Yu, Zhihong Chen, Yajuan Ran, Jiajia Wang, Guangming Dai, Huojin Deng, Xinglong Li & Tao Zhu. (2022) Risk Factors for Length of Hospital Stay in Acute Exacerbation Chronic Obstructive Pulmonary Disease: A Multicenter Cross-Sectional Study. International Journal of General Medicine 15, pages 3447-3458.
Read now
Read now
Guohua Lin, Jiaqi Zheng, Pou Kuan Tang, Yu Zheng, Hao Hu & Carolina Oi Lam Ung. (2022) Effectiveness of Hospital Pharmacist Interventions for COPD Patients: A Systematic Literature Review and Logic Model. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 2757-2788.
Read now
Read now
Marika T Leving, Job FM van Boven, Sinthia Z Bosnic-Anticevich, Joyce van Cooten, Jaime Correia de Sousa, Biljana Cvetkovski, Richard Dekhuijzen, Lars Dijk, Marina García Pardo, Asparuh Gardev, Radosław Gawlik, Iris van der Ham, Elisabeth Sophia Hartgers-Gubbels, Ymke Janse, Federico Lavorini, Tiago Maricoto, Jiska Meijer, Boyd Metz, David B Price, Miguel Roman-Rodríguez, Kirsten Schuttel, Nilouq Stoker, Ioanna Tsiligianni, Omar S Usmani & Janwillem H Kocks. (2022) Suboptimal Peak Inspiratory Flow and Critical Inhalation Errors are Associated with Higher COPD-Related Healthcare Costs. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 2401-2415.
Read now
Read now
Victoria Neches García, Laura Amanda Vallejo-Aparicio, Afisi S Ismaila, Antoni Sicras-Mainar, Aram Sicras-Navarro, Cruz González, Rafael Cuervo, Soham Shukla & Marcos García-Peñuela. (2022) Clinical and Economic Impact of Long-Term Inhaled Corticosteroid Withdrawal in Patients with Chronic Obstructive Pulmonary Disease Treated with Triple Therapy in Spain. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 2161-2174.
Read now
Read now
Reynold A Panettieri Jr, Carlos A Camargo Jr, Tariq Cheema, Sherif G El Bayadi, Stanley Fiel, Tania M Vila, Renu G Jain, Dawn Midwinter, Byron Thomashow, Andrea Ludwig-Sengpiel & David A Lipson. (2022) Effect of Recent Exacerbation History on the Efficacy of Once-Daily Single-Inhaler Fluticasone Furoate/Umeclidinium/Vilanterol Triple Therapy in Patients with Chronic Obstructive Pulmonary Disease in the FULFIL Trial. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 2043-2052.
Read now
Read now
Adem Sav, Sarah T Thomas, Magnolia Cardona, Zoe A Michaleff & Claudia C Dobler. (2022) Treatment Burden Discussion in Clinical Encounters: Priorities of COPD Patients, Carers and Physicians. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 1929-1942.
Read now
Read now
Gema Requena, Victoria Banks, Alexandrosz Czira, Robert Wood, Theo Tritton, Rosie Wild, Chris Compton, Maria Duarte & Afisi S Ismaila. (2022) Characterization of Patients with Chronic Obstructive Pulmonary Disease Initiating Single-Inhaler Long-Acting Muscarinic Antagonist/Long-Acting β2-Agonist Dual Therapy in a Primary Care Setting in England. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 1781-1795.
Read now
Read now
Sanjay Sethi, Barry J Make, Scott B Robinson, Shambhavi Kumar, Michael Pollack, Chad Moretz, Jill Dreyfus, Ann Xi, Dakota Powell & Norbert Feigler. (2022) Relationship of COPD Exacerbation Severity and Frequency on Risks for Future Events and Economic Burden in the Medicare Fee-For-Service Population. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 593-608.
Read now
Read now
Andrea Gabrio, Necdet B Gunsoy, Gianluca Baio, Alan Martin, Victoria F Paly, Nancy Risebrough, David MG Halpin, Dave Singh, Robert A Wise, MeiLan K Han, Fernando J Martinez, Gerard J Criner, Neil Martin, David A Lipson & Afisi S Ismaila. (2022) Single-Inhaler Triple Therapy in Patients with Advanced COPD: Bayesian Modeling of the Healthcare Resource Utilization Data and Associated Costs from the IMPACT Trial. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 1633-1642.
Read now
Read now
David Mannino, Michael Bogart, Guillaume Germain, Shirley P Huang, Afisi S Ismaila, François Laliberté, Young Jung, Sean D MacKnight, Marjorie A Stiegler & Mei Sheng Duh. (2022) Benefit of Prompt versus Delayed Use of Single-Inhaler Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Following a COPD Exacerbation. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 491-504.
Read now
Read now
Michael Bogart, Yuhang Liu, Todd Oakland & Marjorie Stiegler. (2022) Evaluating Triple Therapy Treatment Pathways in Chronic Obstructive Pulmonary Disease (COPD): A Machine-Learning Predictive Model. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 735-747.
Read now
Read now
Mohammed A Almeshari, Ziyad Alshehri, Jaber S Alqahtani, Ali M Alasmari, Ahmed A Alzahrani, Fahad H Alahmadi, Abdullah S Alsulayyim, Faraj K Alenezi & Khalid S Alwadeai. (2022) The Status of Respiratory Care Education in Saudi Arabia: A National Survey of Program Directors. Advances in Medical Education and Practice 13, pages 619-628.
Read now
Read now
Ismail Ozsoy, Muhammed Ihsan Kodak, Caner Kararti, Gulsah Ozsoy, Arzu Erturk & Turhan Kahraman. (2022) Intra- and Inter-Rater Reproducibility of the Face-to-Face and Tele-Assessment of Timed-up and Go and 5-Times Sit-to-Stand Tests in Patients with Chronic Obstructive Pulmonary Disease. COPD: Journal of Chronic Obstructive Pulmonary Disease 19:1, pages 125-132.
Read now
Read now
Carlos Balmaceda, Manuel A. Espinoza, Tomas Abbott & Anne Peters. (2022) Cost-effectiveness analysis: fluticasone furoate/umeclidinium/vilanterol for the treatment of moderate to severe chronic obstructive pulmonary disease from the perspective of the Chilean public health system. Expert Review of Pharmacoeconomics & Outcomes Research 22:5, pages 743-751.
Read now
Read now
Haiyan Ge, Xuanqi Liu, Wenchao Gu, Xiumin Feng, Fengying Zhang, Fengfeng Han, Yechang Qian, Xiaoyan Jin, Beilan Gao, Li Yu, Hong Bao, Min Zhou, Shengqing Li, Zhijun Jie, Jian Wang, Zhihong Chen, Jingqing Hang, Jingxi Zhang & Huili Zhu. (2021) Distribution of COPD Comorbidities and Creation of Acute Exacerbation Risk Score: Results from SCICP. Journal of Inflammation Research 14, pages 3335-3348.
Read now
Read now
Soham Shukla, Dhvani Shah, Alan Martin, Nancy A Risebrough, Robyn Kendall, Claus F Vogelmeier, Isabelle Boucot, Lee Tombs, Leif Bjermer, Paul W Jones, Edward Kerwin, Chris Compton, François Maltais, David A Lipson & Afisi S Ismaila. (2021) Economic Evaluation of Umeclidinium/Vilanterol versus Umeclidinium or Salmeterol in Symptomatic Non-Exacerbating Patients with COPD from a UK Perspective Using the GALAXY Model. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 3105-3118.
Read now
Read now
Xuetao Zeng, Hongfeng Yang, Yan Yang, Xinnan Gu, Xiuqin Ma & Taofeng Zhu. (2021) Associations of Clinical Characteristics and Intestinal Flora Imbalance in Stable Chronic Obstructive Pulmonary Disease (COPD) Patients and the Construction of an Early Warning Model. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 3417-3428.
Read now
Read now
Nobuyuki Hizawa, Koichi Fukunaga, Hisatoshi Sugiura, Yasutaka Nakano, Motokazu Kato, Yutaro Sugiyama, Tomohiro Hanazawa, Toshihiko Kaise, Ruth Tal-Singer, Paul W Jones, Neil Barnes, Chris Compton & Takeo Ishii. (2021) A Prospective Cohort Study to Assess Obstructive Respiratory Disease Phenotypes and Endotypes in Japan: The TRAIT Study Design. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 1813-1822.
Read now
Read now
Kentaro Tamaki, Eishin Sakihara, Hiroaki Miyata, Norimichi Hirahara, Oksana Kirichek, Ryosuke Tawara, Shoko Akiyama, Masayuki Katsumata, Mei Haruya, Takeo Ishii, Edgar P Simard, Bruce E Miller, Ruth Tal-Singer & Toshihiko Kaise. (2021) Utility of Self-Administered Questionnaires for Identifying Individuals at Risk of COPD in Japan: The OCEAN (Okinawa COPD casE finding AssessmeNt) Study. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 1771-1782.
Read now
Read now
Ravi Kalhan, David Slade, Riju Ray, Chad Moretz, Guillaume Germain, François Laliberté, Qin Shen, Mei Sheng Duh, Sean Dale MacKnight & Beth Hahn. (2021) Umeclidinium/Vilanterol Compared with Fluticasone Propionate/Salmeterol, Budesonide/Formoterol, and Tiotropium as Initial Maintenance Therapy in Patients with COPD Who Have High Costs and Comorbidities. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 1149-1161.
Read now
Read now
Anders Løkke, Peter Lange, Jesper Lykkegaard, Rikke Ibsen, Maria Andersson, Sofie de Fine Licht & Ole Hilberg. (2021) Economic Burden of COPD by Disease Severity – A Nationwide Cohort Study in Denmark. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 603-613.
Read now
Read now
Foteini M Rossaki, John R Hurst, Frederik van Gemert, Bruce J Kirenga, Siân Williams, Ee Ming Khoo, Ioanna Tsiligianni, Aizhamal Tabyshova & Job FM van Boven. (2021) Strategies for the prevention, diagnosis and treatment of COPD in low- and middle- income countries: the importance of primary care. Expert Review of Respiratory Medicine 15:12, pages 1563-1577.
Read now
Read now
Paul L. Nguyen, Mohammed M. Uddin, Tanveer Mir, Amir Khalil, Neelambuj Regmi, Amina Pervaiz, Tanveer Hussain, Mohammed Amir Babu, Irfan Ullah, Pragnesh Patel, Prateek Lohia, Ghulam Saydain, Parvaiz A. Koul & Ayman O. Soubani. (2021) Trends in Incidence, and Mortality of Acute Exacerbation of Chronic Obstructive Pulmonary Disease in the United States Emergency Department (2010–2018). COPD: Journal of Chronic Obstructive Pulmonary Disease 18:5, pages 567-575.
Read now
Read now
Barathi Bakthavatsalu, Catherine Walshe & Jane Simpson. (2021) A Systematic Review with Thematic Synthesis of the Experience of Hospitalization in People with Advanced Chronic Obstructive Pulmonary Disease. COPD: Journal of Chronic Obstructive Pulmonary Disease 18:5, pages 576-584.
Read now
Read now
Tom M. A. Wilkinson, Peter Van den Steen, Brigitte Cheuvart, Nathalie Baudson, Monique Dodet, Elisa Turriani, Lauriane Harrington, Nadia Meyer, Simona Rondini, Laura Taddei & Piyali Mukherjee. (2021) Seroprevalence of Bordetella pertussis Infection in Patients With Chronic Obstructive Pulmonary Disease in England: Analysis of the AERIS Cohort. COPD: Journal of Chronic Obstructive Pulmonary Disease 18:3, pages 341-348.
Read now
Read now
Tara Ballav Adhikari, Anupa Rijal, Pawan Acharya, Marieann Högman, Arjun Karki, Arne Drews, Brendan G. Cooper, Torben Sigsgaard, Dinesh Neupane & Per Kallestrup. (2021) Health‐Related Quality of Life of People Living with COPD in a Semiurban Area of Western Nepal: A Community-Based Study. COPD: Journal of Chronic Obstructive Pulmonary Disease 18:3, pages 349-356.
Read now
Read now
Robert M Burkes & Ralph J Panos. (2020) Ultra Long-Acting β-Agonists in Chronic Obstructive Pulmonary Disease. Journal of Experimental Pharmacology 12, pages 589-602.
Read now
Read now
Antoni Sicras-Mainar, Francisco J de Abajo & José Luis Izquierdo-Alonso. (2020) Clinical and Economic Consequences of Inhaled Corticosteroid Doses and Particle Size in Triple Inhalation Therapy for COPD: Real-Life Study. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 3291-3302.
Read now
Read now
Juliana Souza Uzeloto, Alessandra Choqueta de Toledo-Arruda, Bruna Spolador de Alencar Silva, Marjorie de Assis Golim, Aline Márcia Marques Braz, Fabiano Francisco de Lima, Isis Grigoletto & Ercy Mara Cipulo Ramos. (2020) Systemic Cytokine Profiles of CD4+ T Lymphocytes Correlate with Clinical Features and Functional Status in Stable COPD. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 2931-2940.
Read now
Read now
Articles from other publishers (82)
Sanjay SethiSwetha R PalliLindsay G S BengtsonErin K BuysmanBrendan ClarkAndrew SargentAsif ShaikhGary T Ferguson. (2023) Clinical and economic outcomes in patients with chronic obstructive pulmonary disease initiating maintenance therapy with tiotropium bromide/olodaterol or fluticasone furoate/umeclidinium/vilanterol. Journal of Managed Care & Specialty Pharmacy 29:7, pages 791-806.
Crossref
Crossref
Galina L. Ignatova, Elena V. Blinova & Vladimir N. Antonov. (2023) Analysis of the clinical efficacy of vaccination against pneumococcal infection in patients with chronic obstructive pulmonary disease and bronchiectasis. Consilium Medicum 25:3, pages 208-212.
Crossref
Crossref
Chintal H. Shah, Robert M. Reed, Linda Wastila, Eberechukwu Onukwugha, Mathangi Gopalakrishnan & Zafar Zafari. (2023) Direct Medical Costs of COPD in the USA: An Analysis of the Medical Expenditure Panel Survey 2017–2018. Applied Health Economics and Health Policy.
Crossref
Crossref
Barathi Bakthavatsalu, Catherine Walshe & Jane Simpson. (2022) The experience of hospitalization in people with advanced chronic obstructive pulmonary disease: A qualitative, phenomenological study. Chronic Illness 19:2, pages 339-353.
Crossref
Crossref
Marc Miravitlles, Konstantinos Kostikas, Nikoletta Bizymi & Nikolaos Tzanakis. (2023) A Novel Figure and Algorithm for the Gold ABE Classification. Archivos de Bronconeumología.
Crossref
Crossref
Jakob Weiss, Vineet K. Raghu, Dennis Bontempi, David C. Christiani, Raymond H. Mak, Michael T. Lu & Hugo J.W.L. Aerts. (2023) Deep learning to estimate lung disease mortality from chest radiographs. Nature Communications 14:1.
Crossref
Crossref
Irene Prediletto, Gilda Giancotti & Stefano Nava. (2023) COPD Exacerbation: Why It Is Important to Avoid ICU Admission. Journal of Clinical Medicine 12:10, pages 3369.
Crossref
Crossref
Peter Alter, Rudolf A. Jörres & Claus F. Vogelmeier. (2023) Kardiopulmonale Morbidität und Mortalität: Herzerkrankungen und COPD – häufige Partner. Deutsches Ärzteblatt Online.
Crossref
Crossref
Charles Yan, Jeff Round, Ilke Akpinar, Chantal E. Atwood, Lesly Deuchar, Mohit Bhutani, Richard Leigh & Michael K. Stickland. (2023) Cost Analysis of a Transition Care Bundle Compared with Usual Care for COPD Patients Being Discharged from Hospital: Evaluation of a Randomized Controlled Trial. PharmacoEconomics - Open 7:3, pages 493-505.
Crossref
Crossref
Masaru Suzuki, Isao Matsumoto, Masato Ishida, Yoshiharu Horie, Hideyuki Ban, Wataru Takeuchi, Shunki Nakagawa, Tohru Nakagawa, Tetsuhisa Kitamura & Shigeo Muro. (2023) Investigation of time profile of FEV1 across the onset of potential COPD: a retrospective cohort study using medical checkup data in Japan. Scientific Reports 13:1.
Crossref
Crossref
Paolo Zanaboni, Birthe Dinesen, Hanne Hoaas, Richard Wootton, Angela T. Burge, Rochelle PhilpCristino Carneiro Oliveira, Janet Bondarenko, Torben Tranborg Jensen, Belinda R. MillerAnne E. Holland. (2023) Long-term Telerehabilitation or Unsupervised Training at Home for Patients with Chronic Obstructive Pulmonary Disease: A Randomized Controlled Trial. American Journal of Respiratory and Critical Care Medicine 207:7, pages 865-875.
Crossref
Crossref
Faith S. Luyster, Monique Y. Boudreaux-Kelly & Jessica M. Bon. (2023) Insomnia in chronic obstructive pulmonary disease and associations with healthcare utilization and costs. Respiratory Research 24:1.
Crossref
Crossref
Chin-Ling Li, Hui-Chuan Chang, Ching-Wan Tseng, Yuh-Chyn Tsai, Jui-Fang Liu, Meng-Lin Tsai, Meng-Chih Lin & Shih-Feng Liu. (2023) Comparison of BODE and ADO Indices in Predicting COPD-Related Medical Costs. Medicina 59:3, pages 577.
Crossref
Crossref
Tao Cheng, Chao Yang, Cheng Ding & Xianlong Zhang. (2023) Chronic Obstructive Pulmonary Disease is Associated With Serious Infection and Venous Thromboembolism in Patients Undergoing Hip or Knee Arthroplasties: A Meta-Analysis of Observational Studies. The Journal of Arthroplasty 38:3, pages 578-585.
Crossref
Crossref
Juan José Soler-Cataluña, Marc Miravitlles, Alberto Fernández-Villar, José Luis Izquierdo, Juan Luis García-Rivero, Borja G Cosio, José Luis López-Campos & Alvar Agustí. (2023) Exacerbations in COPD: a personalised approach to care. The Lancet Respiratory Medicine 11:3, pages 224-226.
Crossref
Crossref
Anna Katharina Mayr & Arschang Valipour. (2023) Modern Bronchoscopic Treatment Options for Patients with Chronic Bronchitis. Journal of Clinical Medicine 12:5, pages 1854.
Crossref
Crossref
Borja García-Lorenzo, Ania Gorostiza, Nerea González, Igor Larrañaga, Maider Mateo-Abad, Ana Ortega-Gil, Janika Bloemeke, Oliver Groene, Itziar Vergara, Javier Mar, Sarah N. Lim Choi Keung, Theodoros N. Arvanitis, Rachelle Kaye, Elinor Dahary Halevy, Baraka Nahir, Fritz Arndt, Anne Dichmann Sorknæs, Natassia Kamilla Juul, Mikael Lilja, Marie Holm Sherman, Gokce Banu Laleci Erturkmen, Mustafa Yuksel, Tim Robbins, Ioannis Kyrou, Harpal Randeva, Roma Maguire, Lisa McCann, Morven Miller, Margaret Moore, John Connaghan, Ane Fullaondo, Dolores Verdoy & Esteban de Manuel Keenoy. (2023) Assessment of the Effectiveness, Socio-Economic Impact and Implementation of a Digital Solution for Patients with Advanced Chronic Diseases: The ADLIFE Study Protocol. International Journal of Environmental Research and Public Health 20:4, pages 3152.
Crossref
Crossref
Fereshteh Nejaddehbashi, Maryam Radan, Vahid Bayati, Mahin Dianat, Seyyed Ali Mard & Zahra Mansouri. (2023) Adipose-derived mesenchymal stem cells in emphysema: Comparison of inflammatory markers changes in response to intratracheal and systemic delivery method. Tissue and Cell 80, pages 102011.
Crossref
Crossref
Katarzyna Kaczyńska, Monika Jampolska, Piotr Wojciechowski, Dorota Sulejczak, Kryspin Andrzejewski & Dominika Zając. (2023) Potential of Lactoferrin in the Treatment of Lung Diseases. Pharmaceuticals 16:2, pages 192.
Crossref
Crossref
Le Cai, Xu-Ming Wang, Lan Liu, Yi Zhao & Allison Rabkin Golden. (2023) Socioeconomic differentials of trends in the prevalence and economic burden of chronic obstructive pulmonary disease in rural southwest China. BMC Public Health 23:1.
Crossref
Crossref
Vesna Milovanović, Tatjana Adžić-Vukičević, Marija Milić, Jelena Filimonović, Dragana Dimitrijević, Marina Jelić & Maja Stošić. (2023) The clinical features of pneumonia in patients with chronic obstructive pulmonary disease. Glasnik javnog zdravlja 97:1, pages 39-54.
Crossref
Crossref
Druti Hazra, Fayaz SM, Kiran Chawla, Vitali Sintchenko, Elena Martinez, Rahul Magazine & Nayana Siddalingaiah. (2023) The altered lung microbiome dynamics in patients with moderate and severe COPD compared to the healthy group in the Indian population. F1000Research 12, pages 528.
Crossref
Crossref
Manan Shah, Deepak Jain, Surya Prasath & Kevin Dufendach. (2022) Artificial intelligence in bronchopulmonary dysplasia- current research and unexplored frontiers. Pediatric Research 93:2, pages 287-290.
Crossref
Crossref
N. AL WACHAMI, M. LOUERDI, Y. IDERDAR, K. BOUMENDIL & M. CHAHBOUNE. (2023) Chronic obstructive pulmonary disease (COPD) and air pollution: The case of Morocco. Materials Today: Proceedings 72, pages 3738-3748.
Crossref
Crossref
Hala Sacre & Pascale Salameh. 2023. Handbook of Medical and Health Sciences in Developing Countries. Handbook of Medical and Health Sciences in Developing Countries
1
28
.
Jindi Ma, Xuefang Liu, Yumeng Wei, Ruilong Lu, Kexin Xu, Yange Tian & Jiansheng Li. (2022) Effective Component Compatibility of Bufei Yishen Formula III Which Regulates the Mucus Hypersecretion of COPD Rats via the miR-146a-5p/EGFR/MEK/ERK Pathway. Evidence-Based Complementary and Alternative Medicine 2022, pages 1-16.
Crossref
Crossref
Carlos Laranjeira & Marília Dourado. (2022) “Dignity as a Small Candle Flame That Doesn’t Go Out!”: An Interpretative Phenomenological Study with Patients Living with Advanced Chronic Obstructive Pulmonary Disease. International Journal of Environmental Research and Public Health 19:24, pages 17029.
Crossref
Crossref
Majid Balaei-Kahnamoei, Mohammad Al-Attar, Mahdiyeh Khazaneha, Mahboobeh Raeiszadeh, Samira Ghorbannia-Dellavar, Morteza Bagheri, Ebrahim Salimi-Sabour, Alireza Shahriary & Masoud Arabfard. (2022) Overview of herbal therapy of acute and chronic pulmonary disease: a conceptual map. Library Hi Tech.
Crossref
Crossref
Seyyed Mojtaba Ghorashi, Mojtaba Salarifar, Hamidreza Poorhosseini, Saead Sadeghian, Arash Jalali, Hassan Aghajani, Ali-Mohammad Haji-Zeinali & Negar Omidi. (2022) Predictors of in-hospital mortality in diabetic patients with non-ST-elevation myocardial infarction. The Egyptian Heart Journal 74:1.
Crossref
Crossref
Pernille Heyckendorff Secher, Stine Hangaard, Thomas Kronborg, Lisa Korsbakke Emtekær Hæsum, Flemming Witt Udsen, Ole Hejlesen & Clara Bender. (2022) Clinical implementation of an algorithm for predicting exacerbations in patients with COPD in telemonitoring: a study protocol for a single-blinded randomized controlled trial. Trials 23:1.
Crossref
Crossref
Grace Hawthorne, Matthew Richardson, Neil J. Greening, Dale Esliger, Samuel Briggs-Price, Emma J. Chaplin, Lisa Clinch, Michael C. Steiner, Sally J. Singh & Mark W. Orme. (2022) A proof of concept for continuous, non-invasive, free-living vital signs monitoring to predict readmission following an acute exacerbation of COPD: a prospective cohort study. Respiratory Research 23:1.
Crossref
Crossref
Fernanda Inagaki Nagase, Tania Stafinski, Melita Avdagovska, Michael K. Stickland, Evelyn Melita Etruw & Devidas Menon. (2022) Effectiveness of remote home monitoring for patients with Chronic Obstructive Pulmonary Disease (COPD): systematic review. BMC Health Services Research 22:1.
Crossref
Crossref
Tania Stafinski, Fernanda Inagaki Nagase, Melita Avdagovska, Michael K. Stickland & Devidas Menon. (2022) Effectiveness of home-based pulmonary rehabilitation programs for patients with chronic obstructive pulmonary disease (COPD): systematic review. BMC Health Services Research 22:1.
Crossref
Crossref
Ling Zhang, Ayiguli Maitinuer, Zhichuang Lian, Yafang Li, Wei Ding, Wenyi Wang, Chao Wu & Xiaohong Yang. (2022) Home based pulmonary tele-rehabilitation under telemedicine system for COPD: a cohort study. BMC Pulmonary Medicine 22:1.
Crossref
Crossref
Juan J. Olortegui-Rodriguez, David R. Soriano-Moreno, Alejandro Benites-Bullón, Pilar P. Pelayo-Luis & Jorge Huaringa-Marcelo. (2022) Prevalence and incidence of chronic obstructive pulmonary disease in Latin America and the Caribbean: a systematic review and meta-analysis. BMC Pulmonary Medicine 22:1.
Crossref
Crossref
Megan R Chalupsky, Krystal M Craddock, Michael Schivo & Brooks T Kuhn. (2023) Remote Patient Monitoring in the Management of Chronic Obstructive Pulmonary Disease. Journal of Investigative Medicine 70:8, pages 1681-1689.
Crossref
Crossref
Ligang Liu, Armando Silva Almodóvar & Milap C. Nahata. (2022) Medication Adherence in Medicare-Enrolled Older Adults with Chronic Obstructive Pulmonary Disease before and during the COVID-19 Pandemic. Journal of Clinical Medicine 11:23, pages 6985.
Crossref
Crossref
Daniel Franzen. (2022) Cost-effectiveness analysis of surgical lung volume reduction compared with endobronchial valve treatment in patients with severe emphysema. Swiss Medical Weekly 152:4546, pages 40008.
Crossref
Crossref
Fengfeng Lu, Nengluan Xu & Jianshi Zheng. (2022) Association of β2-Agonist Receptor Gene Polymorphisms with Acute Exacerbations of COPD: A Prospective Observational Study. Emergency Medicine International 2022, pages 1-5.
Crossref
Crossref
Chang-Hoon Lee, Mi-Sook Kim, See-Hwee Yeo, Chin-Kook Rhee, Heung-Woo Park, Bo-Ram Yang, Joongyub Lee, Eun-Yeong Cho, Xiaomeng Xu, Aldo Amador Navarro Rojas, Sumitra Shantakumar, Dominique Milea & Nam-Kyong Choi. (2022) Treatment patterns and cost of exacerbations in patients with chronic obstructive pulmonary disease using multiple inhaler triple therapy in South Korea. Respiratory Research 23:1.
Crossref
Crossref
Alexandrosz Czira, Victoria Banks, Gema Requena, Robert Wood, Theo Tritton, Rosie Wild, Chris Compton, Maria Duarte & Afisi S Ismaila. (2022)
Characterisation of patients with chronic obstructive pulmonary disease initiating single-device inhaled corticosteroids/long-acting β
2
-agonist dual therapy in a primary care setting in England
. BMJ Open Respiratory Research 9:1, pages e001243.
Crossref
Crossref
Chantal E. Atwood, Mohit Bhutani, Maria B. Ospina, Brian H. Rowe, Richard Leigh, Lesly Deuchar, Peter Faris, Marta Michas, Kelly J. Mrklas, Jim Graham, Raymond Aceron, Ron Damant, Lee Green, Naushad Hirani, Kelly Longard, Virginia Meyer, Patrick Mitchell, Willis Tsai, Brandie Walker & Michael K. Stickland. (2022) Optimizing COPD Acute Care Patient Outcomes Using a Standardized Transition Bundle and Care Coordinator. Chest 162:2, pages 321-330.
Crossref
Crossref
Arwel W Jones, Joanne E McKenzie, Christian R Osadnik, Elizabeth Stovold, Narelle S Cox, Angela T Burge, Aroub Lahham, Joanna YT Lee, Mariana Hoffman & Anne E Holland. (2022) Non-pharmacological interventions for the prevention of hospitalisations in stable chronic obstructive pulmonary disease: component network meta-analysis. Cochrane Database of Systematic Reviews 2022:7.
Crossref
Crossref
Yujuan Li, Hongchang Gao, Lei Zhao & Jinrui Wang. (2022) Osteoporosis in COPD patients: Risk factors and pulmonary rehabilitation. The Clinical Respiratory Journal 16:7, pages 487-496.
Crossref
Crossref
Tang Deng, Qifeng Huang, Kaiwen Lin, Jin Qian, Qi Li, Lihua Li, Shuangqin Xu, Hongfang Yun, Hangfei Wang, Xinxin Wu, Heng Liu, Guiyun Jin & Xiaoran Liu. (2022) Midkine-Notch2 Pathway Mediates Excessive Proliferation of Airway Smooth Muscle Cells in Chronic Obstructive Lung Disease. Frontiers in Pharmacology 13.
Crossref
Crossref
Yuanjie Qiu, Yan Wang, Nirui Shen, Qingting Wang, Limin Chai, Jian Wang, Qianqian Zhang, Yuqian Chen, Jin Liu, Danyang Li, Huan Chen & Manxiang Li. (2022) Nomograms for Predicting Coexisting Cardiovascular Disease and Prognosis in Chronic Obstructive Pulmonary Disease: A Study Based on NHANES Data. Canadian Respiratory Journal 2022, pages 1-13.
Crossref
Crossref
Xiaohan Yuan, Shuyu Chen, Chuan Sun & Lu Yuwen. (2022) A novel early diagnostic framework for chronic diseases with class imbalance. Scientific Reports 12:1.
Crossref
Crossref
Peter J. Barnes. (2022) Oxidative Stress in Chronic Obstructive Pulmonary Disease. Antioxidants 11:5, pages 965.
Crossref
Crossref
Jakub Szymański, Aurelia Ostrowska, Jarosław Pinkas, Wojciech Giermaziak, Edyta Krzych-Fałta & Mateusz Jankowski. (2022) Awareness of Tobacco-Related Diseases among Adults in Poland: A 2022 Nationwide Cross-Sectional Survey. International Journal of Environmental Research and Public Health 19:9, pages 5702.
Crossref
Crossref
E. A. Orlova, I. P. Dorfman, A. R. Umerova, B. I. Kantemirova, M. A. Orlov & M. A. Abdullaev. (2022) ECONOMIC DAMAGE OF PNEUMOCOCCAL VACCINATION ABSENCE AS A RISK FACTOR FOR COMPLICATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE. Pharmacy & Pharmacology 10:2, pages 187-197.
Crossref
Crossref
Serghei Covantsev, Olga Corlateanu, Stanislav I. Volkov, Rasul Uzdenov, Victor Botnaru & Alexandru Corlateanu. (2022) COPD and Diabetes Mellitus: Down the Rabbit Hole. Current Respiratory Medicine Reviews 18:2, pages 95-103.
Crossref
Crossref
Yahong Chen, Jing Zhang & Jeffrey L. Curtis. (2022) Editorial: Toolkits for Prediction and Early Detection of Acute Exacerbations of Chronic Obstructive Pulmonary Disease. Frontiers in Medicine 9.
Crossref
Crossref
Stefan D. Anker, Leif-Erik Sander, David H. Fitchett, Bernard Zinman, Anne Pernille Ofstad, Christoph Wanner, Ola Vedin, Sabine Lauer, Subodh Verma, Henry K. Yaggi & Silvio E. Inzucchi. (2022) Empagliflozin in patients with type 2 diabetes mellitus and chronic obstructive pulmonary disease. Diabetes Research and Clinical Practice 186, pages 109837.
Crossref
Crossref
Zia Ul Mustafa, Muhammad Salman, Irsa Jamal, Mahpara Kanwal, Muhammad Bilal Riaz, Syed Shahzad Hasan & Amer Hayat Khan. (2022) A pharmacist-led educational intervention to improve nebulization-related knowledge and practices of nursing staff: a pre–post interventional study from Pakistan. Drugs & Therapy Perspectives 38:4, pages 194-200.
Crossref
Crossref
Chin-Ling Li, Mei-Hsin Lin, Yuh-Chyn Tsai, Ching-Wan Tseng, Chia-Ling Chang, Lien-Shi Shen, Ho-Chang Kuo & Shih-Feng Liu. (2022) The Impact of the Age, Dyspnoea, and Airflow Obstruction (ADO) Index on the Medical Burden of Chronic Obstructive Pulmonary Disease (COPD). Journal of Clinical Medicine 11:7, pages 1893.
Crossref
Crossref
Srikanth Katare & Ajit Harsha. (2022) Correlations Between Inflammatory Biomarkers in Tuberculosis-Associated Obstructive Pulmonary Disease Patients With Anxiety and Depression. Cureus.
Crossref
Crossref
Saminan Saminan, Linda Julisafrida, Muhammad Ridwan & Nurul Fajri. (2022) COVID-19 Pandemic: What Considerations Should Be Taken during the Assessment and Management of COPD Exacerbation?. Open Access Macedonian Journal of Medical Sciences 10:F, pages 71-80.
Crossref
Crossref
Alastair Watson & Tom M.A. Wilkinson. (2022) Digital healthcare in COPD management: a narrative review on the advantages, pitfalls, and need for further research. Therapeutic Advances in Respiratory Disease 16, pages 175346662210754.
Crossref
Crossref
Zhu Li, Peiyong He, Hongwei Ding, Ling Gong, Jie Wu, Chengyao Zhong & Daishun Liu. (2022) Association between peripheral blood WBCs C3aR mRNA level and plasma C3a, C3aR, IL-1β concentrations and acute exacerbation of chronic obstructive pulmonary disease. Immunobiology 227:1, pages 152164.
Crossref
Crossref
Mario Francesco Cannavò, Irene Coppolino, Francesco Monaco & Gaetano Caramori. 2022. Encyclopedia of Respiratory Medicine. Encyclopedia of Respiratory Medicine
631
641
.
Ya‐Lin Jiang, Jun Fei, Peng Cao, Chen Zhang, Min‐Min Tang, Jia‐Yi Cheng, Hui Zhao & Lin Fu. (2021) Serum cadmium positively correlates with inflammatory cytokines in patients with chronic obstructive pulmonary disease. Environmental Toxicology 37:1, pages 151-160.
Crossref
Crossref
Celia Gutiérrez Villegas, María Paz-Zulueta, Manuel Herrero-Montes, Paula Parás-Bravo & María Madrazo Pérez. (2021) Cost analysis of chronic obstructive pulmonary disease (COPD): a systematic review. Health Economics Review 11:1.
Crossref
Crossref
Man-Ju Ting, Ya-Hui Tsai, Shih-Ping Chuang, Ping-Huai Wang & Shih-Lung Cheng. (2021) Is PM2.5 associated with emergency department visits for mechanical ventilation in acute exacerbation of chronic obstructive pulmonary disease?. The American Journal of Emergency Medicine 50, pages 566-573.
Crossref
Crossref
Narelle S Cox, Aroub Lahham, Christine F McDonald, Ajay Mahal, Paul O'Halloran, Graham Hepworth, Lissa Spencer, Renae J McNamara, Janet Bondarenko, Heather Macdonald, Samantha Gavin, Angela T Burge, Caitlin Le Maitre, Cade Ringin, Elizabeth Webb, Amanda Nichols, Ling-Ling Tsai, Nia Luxton, Stephanie van Hilten, Mary Santos, Hayley Crute, Megan Byrne, Helen Boursinos, Jennifer Broe, Monique Corbett, Tunya Marceau, Brooke Warrick, Claire Boote, Joanna Melinz & Anne E Holland. (2021) Home-based pulmonary rehabilitation early after hospitalisation in COPD (early HomeBase): protocol for a randomised controlled trial. BMJ Open Respiratory Research 8:1, pages e001107.
Crossref
Crossref
Vita Hagelskjær, Kristina Tomra Nielsen, Cecilie von Bulow, Lisa Gregersen Oestergaard, Maud Graff & Eva Ejlersen Wæhrens. (2021) Evaluating a complex intervention addressing ability to perform activities of daily living among persons with chronic conditions: study protocol for a randomised controlled trial (ABLE). BMJ Open 11:11, pages e051722.
Crossref
Crossref
Mohamed S. Al-Moamary, Nurdan Köktūrk, Majdy M. Idrees, Elif Şen, George Juvelekian, Wajdy Abi Saleh, Zaid Zoumot, Naser Behbehani, Ashraf Hatem, Hosam H. Masoud, Abdelmadjid Snouber & Richard N. van Zyl-Smit. (2021) Unmet need in the management of chronic obstructive pulmonary disease in the Middle East and Africa region: An expert panel consensus. Respiratory Medicine 189, pages 106641.
Crossref
Crossref
Olesya I. Liakh, Mariya A. Derbak, Yelyzaveta S. Sirchak, Mariana I. Tovt-Korshуnska & Yana V. Lazur. (2021) ASSESSMENT OF THE IMPACT OF ANTIREFLUX THERAPY ON THE COURSE OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE. Wiadomości Lekarskie 74:10, pages 2580-2584.
Crossref
Crossref
Rezwan F. Munshi, James R. PellegriniJrJr, Pranavi Patel, Maxim Kashin, James Kang, Robert Sexton, Jose R. Russe, Amgad N. Makaryus, Palakkumar Patel, Samarthkumar Thakkar, Brandon Pelletier, Tinu Abraham, Muhammad Tiwana & Fatima Anjum. (2021) Impact of pulmonary hypertension in patients with acute exacerbation of chronic obstructive pulmonary disease and its effect on healthcare utilization. Pulmonary Circulation 11:4, pages 1-6.
Crossref
Crossref
William D-C. Man & Arwel W. Jones. 2021. Pulmonary Rehabilitation. Pulmonary Rehabilitation
165
181
.
Hussan Zeb, Ahtisham Younas, Israr Ahmed & Anwar Ali. (2020) Self‐care experiences of Pakistani patients with COPD and the role of family in self‐care: A phenomenological inquiry. Health & Social Care in the Community 29:5.
Crossref
Crossref
Chan-Young Kwon, Boram Lee, Beom-Joon Lee, Kwan-Il Kim & Hee-Jae Jung. (2021) Comparative Effectiveness of Western and Eastern Manual Therapies for Chronic Obstructive Pulmonary Disease: A Systematic Review and Network Meta-Analysis. Healthcare 9:9, pages 1127.
Crossref
Crossref
E. A. Orlova, A. R. Umerova, I. P. Dorfman, M. A. Orlov & M. A. Abdullaev. (2021) ЕSTIMATION OF SOCIO-ECONOMIC BURDEN OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE FOR A 5-YEAR PERIOD: A REGIONAL ASPECT. Pharmacy & Pharmacology 9:2, pages 130-138.
Crossref
Crossref
Andrew Cave, Anh Pham, Cliff Lindeman, Boglarka Soos, Tyler Williamson & Neil Drummond. (2021) Chronic obstructive pulmonary disease as a risk factor in primary care: a Canadian retrospective cohort study. npj Primary Care Respiratory Medicine 31:1.
Crossref
Crossref
Li Wang, Xinyi Chen, Xiang Li, Dongli Liu, Xiaojun Wang, Xiaohong Chang & Youmin Guo. (2021) Developing a novel strategy for COPD therapy by targeting Nrf2 and metabolism reprogramming simultaneously. Free Radical Biology and Medicine 169, pages 436-445.
Crossref
Crossref
David Slade, Riju Ray, Chad Moretz, Guillaume Germain, François Laliberté, Qin Shen, Mei Sheng Duh, Sean D. MacKnight & Beth Hahn. (2021) Hospital Admission and Readmission Among US Patients Receiving Umeclidinium/Vilanterol or Tiotropium as Initial Maintenance Therapy for Chronic Obstructive Pulmonary Disease. Pulmonary Therapy 7:1, pages 203-219.
Crossref
Crossref
Janani Vigneswaran, Seth Krantz & John Howington. (2021) Economic Considerations of Lung Volume Reduction Surgery and Bronchoscopic Valves. Thoracic Surgery Clinics 31:2, pages 211-219.
Crossref
Crossref
Gabriele Spina, Pierluigi Casale, Paul S. Albert, Jennifer Alison, Judith Garcia-Aymerich, Christian F. Clarenbach, Richard W. Costello, Nidia A. Hernandes, Jörg D. Leuppi, Rafael Mesquita, Sally J. Singh, Frank W.J.M. Smeenk, Ruth Tal-Singer, Emiel F.M. Wouters, Martijn A. Spruit & Albertus C. den Brinker. (2021) Nighttime features derived from topic models for classification of patients with COPD. Computers in Biology and Medicine 132, pages 104322.
Crossref
Crossref
Wendong Hao, Manxiang Li, Yamei Pang, Weiping Du & Xiaoqi Huang. (2021) Increased chemokines levels in patients with chronic obstructive pulmonary disease: correlation with quantitative computed tomography metrics. The British Journal of Radiology 94:1118, pages 20201030.
Crossref
Crossref
Tao Yang, Chihua Chen & Zhongyuanlong Chen. (2021) The CT pulmonary vascular parameters and disease severity in COPD patients on acute exacerbation: a correlation analysis. BMC Pulmonary Medicine 21:1.
Crossref
Crossref
Huimin Ma, Lu Lu, Haibo Xia, Quanyong Xiang, Jing Sun, Junchao Xue, Tian Xiao, Cheng Cheng, Qizhan Liu & Aimin Shi. (2020) Circ0061052 regulation of FoxC1/Snail pathway via miR-515-5p is involved in the epithelial-mesenchymal transition of epithelial cells during cigarette smoke-induced airway remodeling. Science of The Total Environment 746, pages 141181.
Crossref
Crossref
Feng Li, Xiaofei Liang, Zongru Jiang, Aoli Wang, Junjie Wang, Cheng Chen, Wenliang Wang, Fengming Zou, Ziping Qi, Qingwang Liu, Zhenquan Hu, Jiangyan Cao, Hong Wu, Beilei Wang, Li Wang, Jing Liu & Qingsong Liu. (2020)
Discovery of (
S
)-2-(1-(4-Amino-3-(3-fluoro-4-methoxyphenyl)-1
H
-pyrazolo[3,4-
d
]pyrimidin-1-yl)propyl)-3-cyclopropyl-5-fluoroquinazolin-4(3
H
)-one (IHMT-PI3Kδ-372) as a Potent and Selective PI3Kδ Inhibitor for the Treatment of Chronic Obstructive Pulmonary Disease
. Journal of Medicinal Chemistry 63:22, pages 13973-13993.
Crossref
Crossref
Diego Bonfada, Isabelle Canuto Rabelo Barbosa, Kenio Costa de Lima & Anna Garcia-Altés. (2020) Gasto de internação de idosos em unidades de terapia intensiva nos hospitais privados de uma capital do nordeste brasileiro. Revista Brasileira de Geriatria e Gerontologia 23:2.
Crossref
Crossref